C4orf36


C4orf36 is a protein that in humans is encoded by the c4orf36 gene.

Gene

C4orf36 is located on chromosome 4 at band 4q21.3 on the minus strand. The gene is 21,052 base pairs long and contains 8 exons. Its gene neighborhood includes AFF1-AS1, RPL6P13, SLC10A6, LOC260422, and AFF1. No human paralogs for c4orf36 have been identified.

Expression

RNA-seq and microarray data indicate that the c4orf36 gene is most highly expressed in the placenta, thyroid, ovary, and skin. It is also expressed in the lungs during fetal development, most highly at 17 weeks into development.

Transcript

C4orf36 encodes 24 different mRNA transcripts, including 20 alternatively spliced variants and 4 unspliced forms. The transcript variant 1, the subject of this article, is 908 nucleotides long and contains 5 exons. The promoter for transcript variant 1 spans the base pairs 86892213-86893422 on chromosome 4.

Protein

C4orf36 encodes a 117 amino acid protein with a molecular weight of 13.28 kDa and an isoelectric point of 9.54. It contains a divalent cation tolerance protein CutA motif from amino acids 57-88. No transmembrane domains or N-terminal signal peptides have been identified for c4orf36. The protein is predicted to undergo several post-translational modifications, including myristoylation and phosphorylation.
Immunohistochemistry experiments have shown that the c4orf36 protein is localized to the cytosol and focal adhesion sites in the human U2-OS cell line, cultivated from the bone tissue of an osteosarcoma patient. Staining in human kidney tissue showed strong cytoplasmic and membranous expression within cells of tubules and moderate expression in glomeruli. Data from Human Protein Atlas also indicates that the protein is enriched in several regions of the brain, including the basal ganglia, cerebral cortex, pons, medulla, and in the hippocampus during its formation.

Evolutionary history

C4orf36 orthologs are found in mammals and turtles. The gene is not found in other reptiles, birds, amphibians, fish, invertebrates, or outside of Kingdom Animalia. The gene likely first appeared around 318 million years ago, when mammals diverged from birds and reptiles.
The following table presents a diverse subset of c4orf36 orthologs found using BLAST searches. Within mammals, the sequence identity of the selected orthologs ranges from 99.1% to 47%. Within turtles, the sequence identity ranges from 34.8% to 32.2%.
Scientific NameCommon NameNCBI Accession #Protein Length Sequence Identity to Humans
Homo sapiensHumanNP_653246.2117100.0
Pan troglodytesChimpanzeePNI41451.111399.1
Halichoerus grypusGray SealXP_035952662.111775.2
Equus caballusHorseXP_02349353011775.2
Tursiops truncatesCommon bottlenose dolphinXP_019782327.111775.2
Manis pentadactylaChinese pangolinXP_036752164.111773.5
Choloepus didactylusSouthern two-toed slothXP_037684921.111773.5
Galeopterus variegatusSunda flying lemurXP_008566526.111772.7
Bos TaurusCattleXP_015327194.111772.7
Vulpes VulpesRed foxXP_025853915.111768.4
Condylura cristataStar-nosed moleXP_004681481.111767.5
Eptesicus fuscusBig brown batXP_008141802.111666.7
Mus musculusMouseNP_00115702211764.1
Monodelphis domesticaGray short-tailed opossumXP_00749599411852.1
Ornithorhynchus anatinusPlatypusXP_007658949.115947.0
Trachemys scripta elegansSlider turtleXP_034628022.111734.8
Chrysemys picta belliiPainted turtleXP_04271236211734.8
Dermochelys coriaceaLeatherback sea turtleXP_038255787.111733.9
Chelonia mydasGreen sea turtleXP_043401238.111733.0
Mauremys muticaYellow pond turtleKAH117000211732.2

C4orf36 is predicted to evolve more rapidly than other common human proteins, including cytochrome C and fibrinogen alpha.

Clinical significance

Immunostaining of c4orf36 in syncytiotrophoblast cells of mid-gestation human embryos showed a dense punctate pattern consistent with that of c4orf36’s fungal protein analog, dynein light chain, which is involved in intracellular cargo transport and other cellular processes. In another study, ovarian cancer cell lines were treated with gemcitabine. Higher c4orf36 expression was associated with in vitro chemoresistance to the drug, indicating that increased c4orf36 expression may be related to decreased OCVA patient survival. Furthermore, microarray data suggests that C4orf36 expression levels are higher in the saliva of pre-treatment pancreatic cancer patients than that of healthy controls.
In one study on adaptogenic plants, neuroglia cell lines were treated with Rhaponticum carthamoides, which promotes non-specific stress resistance and may mitigate the onset of senescence. C4orf36 was significantly deregulated in neuroglia cell lines after RC treatment, indicating that tighter c4orf36 regulation may play a role in the development of age-related disorders. A study on chondrogenesis found that c4orf36 has an oscillatory expression pattern coupled to that of ATP, indicating a potential link to skeletal development during embryogenesis.

Mutations

Chemically significant amino acid changes in conserved regions of the c4orf36 protein were found with NCBI SNPGeneView.
dbSNP rs# Cluster IDMutationFunction
rs149531474M1TNo protein
rs1200223723P70LMissense
rs201168053E78*Nonsense
rs908052987L86PMissense
rs762808044P113RMissense